Cargando…

Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison

Non-cystic fibrosis (non-CF) bronchiectasis is a condition characterized by an airway inflammatory response to bacterial pathogens. Frequent exacerbations have a major influence on the quality of life. Macrolide antibiotics have not only antibacterial but also immune-regulation effects. It is proved...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wen, Qin, Zhong, Gao, Jie, Jiang, Zhibin, Chai, Yihui, Guan, Liancheng, Chen, Yunzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302979/ https://www.ncbi.nlm.nih.gov/pubmed/30101613 http://dx.doi.org/10.1177/1479972318790269

Ejemplares similares

The Role of Macrolides in Childhood Non-Cystic Fibrosis-Related Bronchiectasis
por: Masekela, R., et al.
Publicado: (2012)

Macrolide Therapy in Adults and Children with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and Meta-Analysis
por: Gao, Yong-hua, et al.
Publicado: (2014)

Pharmacokinetics of Macrolide Antibiotics and Transport into the Interstitial Fluid: Comparison among Erythromycin, Clarithromycin, and Azithromycin
por: Kobuchi, Shinji, et al.
Publicado: (2020)

The Role of Macrolides in Noncystic Fibrosis Bronchiectasis
por: Figueiredo, Bruna de Campos Guimarães e, et al.
Publicado: (2011)

Long-term macrolide treatment for non-cystic fibrosis bronchiectasis in children: a meta-analysis
por: Lee, Eun, et al.
Publicado: (2021)

Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis Bronchiectasis
por: Choo, Jocelyn M., et al.
Publicado: (2018)

The efficacy of azithromycin to prevent exacerbation of non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled studies
por: Li, Kui, et al.
Publicado: (2022)

Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trials
por: Fan, Li-Chao, et al.
Publicado: (2015)

Scaffold Modifications in Erythromycin Macrolide Antibiotics. A Chemical Minireview
por: Undheim, Kjell
Publicado: (2020)

Global impact of bronchiectasis and cystic fibrosis
por: Redondo, Margarida, et al.
Publicado: (2016)

Comparison of azithromycin and erythromycin in the treatment of mycoplasma pneumonia in children
por: Han, Rui, et al.
Publicado: (2020)

Role of vitamin D in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Moustaki, Maria, et al.
Publicado: (2017)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Azithromycin and the microbiota of cystic fibrosis sputum
por: Acosta, Nicole, et al.
Publicado: (2021)

Cystic fibrosis modulator therapy can reverse cystic bronchiectasis
por: Middleton, Peter G., et al.
Publicado: (2023)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Bergin, David A, et al.
Publicado: (2013)

Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Alyasin, Soheila, et al.
Publicado: (2018)

Exercise capacity in patients with cystic fibrosis vs. non-cystic fibrosis bronchiectasis
por: Bar-Yoseph, Ronen, et al.
Publicado: (2019)

Bordetella bronchiseptica in non-cystic fibrosis bronchiectasis
por: Karamooz, Elham, et al.
Publicado: (2018)

Brazilian consensus on non-cystic fibrosis bronchiectasis
por: Pereira, Mônica Corso, et al.
Publicado: (2019)

Randomized Trial of Erythromycin and Azithromycin for Treatment of Chlamydial Infection in Pregnancy
por: Rosenn, Marc F., et al.
Publicado: (1995)

From Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials
por: Jelić, Dubravko, et al.
Publicado: (2016)

The effect of erythromycin and clarithromycin versus azithromycin on serum valproate concentration
por: Albanji, Muradi, et al.
Publicado: (2022)

Selection of Macrolide and Non-Macrolide Resistance with Mass Azithromycin Distribution: A Community-Randomized Trial
por: Doan, Thuy, et al.
Publicado: (2020)

Meta-analysis of macrolide maintenance therapy for prevention of disease exacerbations in patients with noncystic fibrosis bronchiectasis
por: Wang, Donghai, et al.
Publicado: (2019)

Non-cystic fibrosis bronchiectasis: review and recent advances
por: Livnat, Galit, et al.
Publicado: (2009)

Evidence of Inhaled Tobramycin in Non-Cystic Fibrosis Bronchiectasis
por: Vendrell, Montserrat, et al.
Publicado: (2015)

Children with recurrent pneumonia and non-cystic fibrosis bronchiectasis
por: Patria, Maria Francesca, et al.
Publicado: (2016)

Non-cystic fibrosis bronchiectasis in the elderly: current perspectives
por: Quinn, Tom M, et al.
Publicado: (2018)

Diagnostic imaging in adult non-cystic fibrosis bronchiectasis
por: Juliusson, Gunnar, et al.
Publicado: (2019)

Imaging in non-cystic fibrosis bronchiectasis and current limitations
por: Ledda, Roberta Eufrasia, et al.
Publicado: (2021)

The effect of azithromycin on sputum inflammatory markers in bronchiectasis
por: Terpstra, L. C., et al.
Publicado: (2023)

Azithromycin versus erythromycin infusions prior to endoscopy in upper gastrointestinal bleeding
por: Issa, Danny, et al.
Publicado: (2022)

Comparative safety of inhaled corticosteroids and macrolides in Medicare enrolees with bronchiectasis
por: Henkle, Emily, et al.
Publicado: (2022)

16-membered ring macrolides and erythromycin induce ermB expression by different mechanisms
por: He, Weizhi, et al.
Publicado: (2022)

Assessment of the Non-Cystic Fibrosis Bronchiectasis Severity: The FACED Score vs the Bronchiectasis Severity Index
por: Minov, J, et al.
Publicado: (2015)

The Bronchiectasis Exacerbation Diary: a novel patient-reported outcome for non-cystic fibrosis bronchiectasis
por: Shih, Vivian H., et al.
Publicado: (2023)

Lung clearance index in adults with non-cystic fibrosis bronchiectasis
por: Gonem, Sherif, et al.
Publicado: (2014)

Adrenal insufficiency in patients with stable non-cystic fibrosis bronchiectasis
por: Rajagopala, Srinivas, et al.
Publicado: (2014)

Adrenal reserve in acute exacerbation of non-cystic fibrosis bronchiectasis
por: Rajagopala, Srinivas, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c2i3m2mgmd30rkvt0tmrlimdjn